On 3 April, WHO announced that it will work together with UNICEF on COVID-19 response through Solidarity Response Fund. By 7 April the WHO had accepted two diagnostic tests for procurement under the Emergency Use Listing procedure (EUL) for use during the COVID-19 pandemic, in order to increase access to quality-assured, accurate tests for the disease.[33] Both in vitro diagnostics, the tests are genesig Real-Time PCR Coronavirus (COVID-19) manufactured by Primerdesign, and cobas SARS-CoV-2 Qualitative assay for use on the cobas® 6800/8800 Systems by Roche Molecular Systems. These tests can also be supplied by the United Nations and other procurement agencies supporting the COVID-19 response.